Translate Bio Inc (NASDAQ:TBIO)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - TBIO

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - TBIO

  • Market Cap$1.042bn
  • SymbolNASDAQ:TBIO
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS89374L1044

Company Profile

Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.

Latest TBIO news

Currently there for this company. Visit our news hub for other news .